Vaccines
-
A Call to Action: Rebuilding Trust in Vaccines Amid Uncertainty
on
Read more: A Call to Action: Rebuilding Trust in Vaccines Amid UncertaintyDemetre Daskalakis, MD, MPH, chief medical officer of Callen-Lorde Community Health Center, offered an overview of the landscape and uncertain future of vaccine adoption in the United States during Sunday morning’s Keynote Series at the ATS 2026 International Conference. His lecture traced major milestones in immunization while urging health care leaders to defend science-driven decision…
-
Sunday Keynote Traces Past, Present, and Future of Vaccines with Stories From the Field
on
Read more: Sunday Keynote Traces Past, Present, and Future of Vaccines with Stories From the FieldDemetre Daskalakis, MD, MPH, chief medical officer at Callen-Lorde and former director of the National Center for Immunization and Respiratory Diseases at the CDC, will kick off the ATS 2026 International Conference Keynote Series with stories from the field to examine the past, present, and future of vaccine adoption and innovation from 8–8:45 a.m. on…
-
Clinical Year in Review Sessions Frame New Evidence and Guidelines Through A Practical Lens
on
Read more: Clinical Year in Review Sessions Frame New Evidence and Guidelines Through A Practical LensSunday marks the start of this year’s Clinical Year in Review series at the ATS 2026 International Conference, offering a rare opportunity to learn about timely, impactful insights that could significantly affect care. Ayodeji Adegunsoye, MD, PhD, MSc, chair of this year’s series, previewed the first two sessions, scheduled for 9:15–10:45 a.m. on Sunday and…
-
New Vaccine Adoption Strategies from Multi-Year Grant Initiative to be Shared at ATS 2026 Orlando
on
Read more: New Vaccine Adoption Strategies from Multi-Year Grant Initiative to be Shared at ATS 2026 OrlandoThe ATS is one of seven specialty societies awarded a grant by the Council of Medical Specialty Societies and CDC to increase COVID-19, influenza, and routine vaccination rates among high-risk adult patients in the United States. Data collection for this initiative wrapped in summer 2025, and the ATS is now using its findings to build…